Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING5
READOUTS ≤12 MONTHS2
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| HL-1186 NCT07147049 |
P2 | Recruiting | Moderate to Severe Acute Postoperative Pain | 72 | 2025-12 |
| HL-1186 NCT07311369 |
P2 | Recruiting | Moderate to Severe Acute Postoperative Pain | 40 | 2026-02 |
| HTMC0658 NCT07174115 |
P2 | Recruiting | Chronic Sinusitis Without Nasal Polyps | 30 | 2026-04 |
| HL-1186 NCT07159243 |
P2 | Not yet recruiting | Diabetic Peripheral Neuropathic Pain | 180 | 2026-10 |
| YD0743 NCT07413094 |
P2 | Recruiting | Sepsis | 309 | 2026-12 |
| HL-1186 NCT07758920 |
P2 | Recruiting | Postherpetic Neuralgia ( PHN ) | 200 | 2027-06 |